Anneo Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 28-10-2024
- Paid Up Capital ₹ 0.10 M
as on 28-10-2024
- Company Age 4 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue 273.20%
(FY 2023)
- Profit 423.60%
(FY 2023)
- Ebitda 564.62%
(FY 2023)
- Net Worth 408.34%
(FY 2023)
- Total Assets 141.46%
(FY 2023)
About Anneo Biotech
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Balaji Srivasanth, Srinivasan Venkateshwaran, and Balaji Srinidhi serve as directors at the Company.
- CIN/LLPIN
U24299TN2020PTC139039
- Company No.
139039
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Oct 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Anneo Biotech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Balaji Srivasanth  | Director | 28-Oct-2020 | Current |
| Srinivasan Venkateshwaran | Director | 28-Oct-2020 | Current |
| Balaji Srinidhi | Director | 28-Oct-2020 | Current |
Financial Performance of Anneo Biotech.
Anneo Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 273.2% increase. The company also saw a substantial improvement in profitability, with a 423.6% increase in profit. The company's net worth Soared by an impressive increase of 408.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Anneo Biotech?
Unlock access to Anneo Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Plataprop Ventures Private LimitedActive 5 months 5 days
Balaji Srivasanth, Srinivasan Venkateshwaran and 1 more are mutual person
- Picstill Infotec Private LimitedActive 7 years 2 months
Balaji Srivasanth and Balaji Srinidhi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Anneo Biotech?
Anneo Biotech has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anneo Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anneo Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
